|
Issue Dtd. 16th to 30th November 2002
INSIDE
FOCUS
HOSPINEWS
LEGALITIES
MANAGEMENT
ALMANAC
EDIT
OPED
RENDEZVOUS
TECHNONOLOGY
EVENTS
CONVERSATION
PERSPECTIVE
HEALTHCARE IN KERALA

ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US


 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Exp. Hotelier & Caterer
  Exp. Travel & Tourism
  Exp. Backwaters
  Exp. Pharma Pulse
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express
-
Home > Technology- > Full Story

New technology for continuous blood glucose measurement

EHM News Bureau -

The M V Diabetes Specialities Centre (MVDSC) at Chennai has introduced a new technology for the evaluation of diabetes control called Continuous Glucose Monitoring System (CGMS). CGMS helps to measure the blood glucose levels of a patient continuously upto 72 hours at a time and provides a detailed analysis and graph for the whole period. CGMS has been made possible by the development of a unique glucose sensor which measures the body’s glucose levels from the interstitial fluid just beneath the skin. The sensor measures the glucose every 10 seconds and gives an average reading every 5 minutes for 72 hours (288 readings every 24 hours). This information is stored in a monitor (which is the size of a pager) and this can be clipped to the waist of the patient. The test is continued for 3 days and the patient is allowed to continue his or her normal activities. The data when downloaded into a computer, produces a graph which provides very valuable information about glucose fluctuations during the whole day and is an excellent indication of the high (peaks) and low (troughs or valleys) sugar readings.

CGMS is especially useful in detecting silent hypoglycemic episodes particularly in the night and in the treatment of "brittle diabetes". It also helps to solve the hitherto unexplained puzzle as to why some patients have near normal blood sugar levels when tested in the clinic in the usual way by doing fasting and postprandial blood sugar estimators appear to have unsatisfactory glycosylated haemoglobin levels (3 months control test). Uncontrolled diabetes predisposes on to develop long term complications affecting the eyes, kidneys, heart, feet and nerves. The CGMS technology has been approved for clinical use by the FDA in the USA and MVDSC is the first to use this new technology.
Back to Top


Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world.
This entire site is compiled in Mumbai by The Business Publications Division of the Indian Express Group of
Newspapers. Please Email our Webmaster for any queries / broken links on this site